Skip to main content
. 2023 Nov 8;23(8):4665–4672. doi: 10.1007/s10238-023-01249-0

Table 1.

Patient baseline characteristics

Characteristic Total (n = 261)
Age
 Median (range) 64 (27–88)
 Age > 60, n (%) 157 (60)
Sex, n (%)
 Female 161 (62)
 Male 100 (38)
ECOG score
 0–1 148 (57)
 2–3 113 (43)
Extranodal site, n (%)
 Yes 160 (61)
 No 101 (39)
Bulky disease, n (%) (≥ 10 cm)
 Yes 24 (9)
 No 237 (91)
Stage, n (%)
 I 36 (14)
 II 57 (22)
 III 75 (29)
 IV 93 (34)
Elevated LDH, n (%)
 Yes 124 (48)
 No 137 (42)
Bone marrow involvement
 Yes 33 (13)
 No 228 (87)
IPI score
 0–2 132 (51)
 3–5 129 (49)
Subtype n (%)
 GCB 78 (30)
 Non-GCB 183 (70)
NKCC4, n (%)
 > 135 cell/μl 111 (43)
 < 135 cell/μl 150 (57)

ECOG Eastern Cooperative Oncology Group; LDH serum lactate dehydrogenase; IPI International Prognostic Index; GCB germinal center B cell-like; NKCC4 absolute peripheral blood NK cell count after four cycles of R-CHOP